BNP Paribas Bonus Zert AMD 27.06..../ DE000PC1UKF2 /
6/5/2024 8:52:24 AM | Chg.-0.05 | Bid9:20:06 AM | Ask9:20:06 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
137.58EUR | -0.04% | 137.59 Bid Size: 750 |
- Ask Size: - |
Advanced Micro Devic... | - USD | 6/27/2024 | Call |
GlobeNewswire
6/4
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
6/3
AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Road...
GlobeNewswire
6/3
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire
5/28
AMD Chair and Chief Executive Officer Dr. Lisa Su to Deliver the Opening Keynote at Computex 2024
GlobeNewswire
5/28
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizuma...
GlobeNewswire
5/28
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
5/21
AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire
5/21
AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...
GlobeNewswire
5/21
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire
5/21
YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
GlobeNewswire
5/20
Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs
Newsfile Corp
5/16
FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization
GlobeNewswire
5/15
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...
GlobeNewswire
5/14
Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire
5/14
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update